Holen Sie sich die Stockscreener-App
0.2257
4.89%
-0.0116
Handel nachbörslich:
.22
-0.0057
-2.53%
Azitra Inc Aktie (AZTR) Neueste Nachrichten
What drives Azitra Inc. stock priceExponential wealth increase - jammulinksnews.com
Azitra Inc. Stock Analysis and ForecastHigh-yield market plays - Autocar Professional
What analysts say about Azitra Inc. stockFree Stock Market Trend Analysis - jammulinksnews.com
Why Azitra Inc. stock attracts strong analyst attentionSafer Investing With Bigger Upside - Newser
Is Azitra Inc. a good long term investmentConsistently exceptional gains - Autocar Professional
What makes Azitra Inc. stock price move sharplyCapital Preservation Investment Ideas - Newser
How Azitra Inc. stock performs during market volatilityShort Term Profit Focus - Newser
A Closer Look at Azitra Inc (AZTR) Stock Gains - investchronicle.com
Azitra Inc. issues new warrants in connection with stock sale - MSN
Azitra shareholders approve doubling of authorized common stock - Investing.com
Azitra shareholders approve doubling of authorized common stock By Investing.com - Investing.com Canada
Azitra Inc Approves Director Elections and Share Issuance - TipRanks
Azitra Inc Plans Stock Increase at Annual Meeting - TipRanks
Azitra reports safety data from Netherton syndrome treatment trial - Investing.com
Azitra reports safety data from Netherton syndrome treatment trial By Investing.com - Investing.com South Africa
AZTR’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com
Azitra Inc Announces Positive Phase 1b Trial Results - TipRanks
Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome - PR Newswire
Azitra (NYSEAMERICAN:AZTR) Stock Price Up 2% – Still a Buy? - Defense World
Azitra Inc (AZTR) Stock: A Year of Market Fluctuations - investchronicle.com
Azitra Reveals Latest Clinical Progress: Two Novel Dermatology Treatments Take Center Stage at BIO 2025 - Stock Titan
Revolutionary Skin Microbiome Treatment Could Help Cancer Patients Stay on Life-Saving Therapy - Stock Titan
Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash - PR Newswire
FY2025 EPS Estimates for Azitra Lifted by Zacks Small Cap - Defense World
What is Zacks Small Cap’s Forecast for Azitra Q2 Earnings? - Defense World
AZTR: ATR-04 Trial to Dose 1st Patient Mid-2025 - MSN
Azitra (NYSEAMERICAN:AZTR) Trading Up 0.9% – Time to Buy? - Defense World
Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash - Seeking Alpha
Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates - Nasdaq
Azitra Advances Novel Skin Disease Treatments: Key Trial Results Expected in 2025 - Stock Titan
AZTRAzitra Inc Latest Stock News & Market Updates - Stock Titan
Stock Of Azitra Inc (AMEX: AZTR) Jumped By 6.67 Percent Over The Past Month, Is There Room For Upside? - Marketing Sentinel
Azitra Inc (AZTR)’s Day in Review: Closing at 0.30, Down by -6.51 - DWinneX
Azitra Inc (AZTR) Stock: Navigating Drops and Gains - investchronicle.com
Azitra Inc [AZTR] Investment Appeal on the Rise - knoxdaily.com
Azitra Inc (AMEX:AZTR) stock: You might be surprised - uspostnews.com
Stocks of Azitra Inc (AZTR) are poised to climb above their peers - Sete News
3.32%
1.57%
Kapitalisierung:
|
Volumen (24h):